1984
DOI: 10.1097/00006231-198407000-00007
|View full text |Cite
|
Sign up to set email alerts
|

Potential radiation dose to a breast-fed infant following administration of sodium 32P-phosphate to the mother

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2014
2014

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Having objective information on medications and their effect on nursing children can enable healthcare providers and mothers to make the most educated choice regarding drug therapy and breast-feeding. 168 J PHARM TECHNOL I VOLUME 20 monitor for symptoms of rash and hematoma 64, 65 1 case of thrombocytopenia purpura and anemia concentrations in infants considered low Vigabatrin racemic mixture of S-enantiomer (active) and R-enantiomer not addressed 57 (inactive) has low molecular weight and is not protein bound maximum infant dose is 2-3.6% that of the maternal dose for the R-enantiomer and 0.6-0.96% of maternal dose for the S-enantiomer no cases of nursing infants exposed to drug use with caution and monitor infant Zonisamide (Zonegran) after a 300-mg dose, amount in milk equal to that in maternal not addressed 73 plasma readily transported into milk determine concentrations individually if breast-feeding AAP = American Academy of Pediatrics. a Some nurslings whose mothers are receiving antiepileptic therapy have increased sedation and may stop feeding early; this should be closely monitored.…”
Section: Discussionmentioning
confidence: 99%
“…Having objective information on medications and their effect on nursing children can enable healthcare providers and mothers to make the most educated choice regarding drug therapy and breast-feeding. 168 J PHARM TECHNOL I VOLUME 20 monitor for symptoms of rash and hematoma 64, 65 1 case of thrombocytopenia purpura and anemia concentrations in infants considered low Vigabatrin racemic mixture of S-enantiomer (active) and R-enantiomer not addressed 57 (inactive) has low molecular weight and is not protein bound maximum infant dose is 2-3.6% that of the maternal dose for the R-enantiomer and 0.6-0.96% of maternal dose for the S-enantiomer no cases of nursing infants exposed to drug use with caution and monitor infant Zonisamide (Zonegran) after a 300-mg dose, amount in milk equal to that in maternal not addressed 73 plasma readily transported into milk determine concentrations individually if breast-feeding AAP = American Academy of Pediatrics. a Some nurslings whose mothers are receiving antiepileptic therapy have increased sedation and may stop feeding early; this should be closely monitored.…”
Section: Discussionmentioning
confidence: 99%